GlassScriptPhysician profile
Christopher Leibold
NPI 1306379086
$14,021.10
in general payments reported to CMS, 2019-2025
16 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2021: $158 · 2022: $5,101 · 2023: $2,933 · 2024: $3,989 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,614 · Grant: $2,500 · Travel and Lodging: $1,816 · Food and Beverage: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,614.17 |
| Grant | $2,500.00 |
| Travel and Lodging | $1,816.43 |
| Food and Beverage | $1,626.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,027.42 | 2023-2024 | Real Intelligence |
| Rock Medical Orthopedics, INC. | $3,667.26 | 2022 | |
| Zimmer Biomet Holdings, INC. | $1,799.88 | 2023-2025 | Persona, Rosa, Hammr Curved G7 Impactor |
| Stryker Corporation | $1,611.67 | 2022-2023 | Radius, Mako, Insignia |
| Depuy Synthes Sales INC. | $842.76 | 2024 | Actis |
| Si-Bone, INC. | $269.81 | 2021-2022 | |
| Omnilife Science, INC | $207.33 | 2024 | Various Products |
| Heron Therapeutics, INC. | $124.95 | 2024 | Zynrelef |
| Solventum Corporation | $116.68 | 2024-2025 | Prevena |
| Medtronic USA, INC. | $108.13 | 2019 | |
| Cdc Medical LLC | $96.97 | 2019 | |
| Medical Device Business Services, INC. | $44.20 | 2024 | |
| Microport Orthopedics INC | $43.76 | 2024 | Mpo Medial Pivot Knee |
| Ethicon US, LLC | $32.33 | 2024 | Vistaseal |
| Pacira Pharmaceuticals Incorporated | $16.77 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Leibold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.